Dr. Bernardo Lustosa

Hebe Life Science is a pioneering biotechnology pharmaceutical company in Latin America, committed to developing safe and effective solutions in healthcare. We are the first company in Latin America to produce type A botulinum toxin, in addition to injectable hyaluronic acid and biostimulators, offering excellent products to meet the needs of the therapeutic, medical, and aesthetic markets. - Hebe Life Science é uma farmacêutica biotecnológica pioneira na América Latina, comprometida com o desenvolvimento de soluções seguras e eficazes na área da saúde. Somos a primeira empresa na América Latina a produzir toxina botulínica tipo A, além de ácido hialurônico injetável e bioestimuladores, oferecendo produtos de excelência para atender às necessidades dos mercados terapêutico, médico e estético.

Reaction is a global organization invested in solving the toughest global problems. We were founded by over 200 Stanford alumni executives across 47 countries. Our mission is to improve a billion lives, within a decade, by thought leadership and scaling innovations that change the world. Reaction is creating exponential change. Why now? Because more innovations will be created in more countries and industries over the next decade than in the previous 50 years. Many that offer the potential to solve pressing global issues will fail to reach the markets that need them the most. Reaction was founded by a diverse team of global leaders who united to solve this problem. We share a vision for a world where thought leadership and innovation can change more lives in less time.

Gestão de despesas da sua empresa como deve ser. Simples. Faça Simples. Abra sua conta. Dúvidas, atendimento e ouvidoria: https://ajuda.contasimples.com/

big_bets is a fund that invests exclusively in software-intensive companies, that is, in companies built around code and data. There is a very important belief behind everything we do: we believe that the destiny of every atom is to become an electron. And precisely when an atom is turning into an electron is when the grand investment opportunities emerge. Think about it, this occurred with media (all the money that once flowed into the atoms of magazines, newspapers, radios, and TVs is now in the electrons of social networks, search engines, e-commerces, etc.), with financial products (in the past, banks had a branch on every corner, but today theres a branch in everyones pocket), with software (the older generation will recall buying software CDs at newsstands or having numerous servers within companies, today much of this is in the cloud), and with entertainment (no need to mention that books, music, and films have become apps on your phone) and so forth. Its precisely for this reason that our investment thesis is centered on identifying the largest industries currently transitioning from atoms to electrons and investing in and backing the entrepreneurs who are best equipped to accelerate this transformation. Therefore, our investments are highly agnostic, covering areas like financial services (Conta Simples, Ume, and Justos), identity (Unico), pharmaceutical industry (Menten AI and Pepper Bio), diagnostics (Huna), media (Festalab, Prota, and Newtail), primary education (Studdy), energy distribution (Lemon), devtools (Lazy AI, DataMilk, NuMind, Croct), among others.

Hebe Life Science is a pioneering biotechnology pharmaceutical company in Latin America, committed to developing safe and effective solutions in healthcare. We are the first company in Latin America to produce type A botulinum toxin, in addition to injectable hyaluronic acid and biostimulators, offering excellent products to meet the needs of the therapeutic, medical, and aesthetic markets. - Hebe Life Science é uma farmacêutica biotecnológica pioneira na América Latina, comprometida com o desenvolvimento de soluções seguras e eficazes na área da saúde. Somos a primeira empresa na América Latina a produzir toxina botulínica tipo A, além de ácido hialurônico injetável e bioestimuladores, oferecendo produtos de excelência para atender às necessidades dos mercados terapêutico, médico e estético.

Empreender é a nossa causa. Trabalhamos para tornar o país referência mundial em empreendedorismo. Lutamos para que os empreendedores brasileiros sejam os melhores do mundo, construindo grandes empresas, criando novos mercados, gerando empregos. Acreditamos que o empreendedorismo de alto impacto é o caminho para tornar o Brasil um país com mais oportunidades e um lugar melhor para se viver.

A Takaoka Anestesia é uma empresa de anestesia que atende a serviços de saúde. Contamos com profissionais qualificados e apoio de áreas administrativas que, juntos, fazem a operação acontecer. RT: Dr. Everaldo Agnelo da Silva - CRM: 87102

Reaction is a global organization invested in solving the toughest global problems. We were founded by over 200 Stanford alumni executives across 47 countries. Our mission is to improve a billion lives, within a decade, by thought leadership and scaling innovations that change the world. Reaction is creating exponential change. Why now? Because more innovations will be created in more countries and industries over the next decade than in the previous 50 years. Many that offer the potential to solve pressing global issues will fail to reach the markets that need them the most. Reaction was founded by a diverse team of global leaders who united to solve this problem. We share a vision for a world where thought leadership and innovation can change more lives in less time.

Gestão de despesas da sua empresa como deve ser. Simples. Faça Simples. Abra sua conta. Dúvidas, atendimento e ouvidoria: https://ajuda.contasimples.com/